The Latest Breaking News from Moderna

Ready or not, back-to-school season is here, and kids will be bringing home more than homework. They’ll be carrying germs, too.

What's the best part of a big S&P 500 sell-off? It can open up new ways to make money.

Moderna stock, which lost 27% of its value over two days, tumbled again Monday on a rare downgrade amid uncertainty for its vaccines.

Job seekers need to hone a personal brand, upskill themselves, and stay resilient.

It may be earnings season for the S&P 500 — but revenue is on top of many investors' minds.

Moderna cut its outlook early Thursday despite delivering nearly double strong quarterly sales. Moderna stock tumbled.

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

As part of the Biden admin's pandemic preparedness strategy, Moderna will develop an mRNA vaccine for H5N1

Moderna stock tumbled Wednesday after the company said its newly approved RSV vaccine was only about 50% effective after 18 months.

Moderna recently outperformed the S&P 500, and Wall Street analysts are moderately optimistic about the stock’s prospects.